Sun Pharmaceutical Industries Limited has informed the Exchange about Order Vacating Preliminary Injunction on LEQSELVI
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the stock exchange that a court order vacating the preliminary injunction on LEQSELVI has been issued. LEQSELVI is Sun Pharma's hair loss treatment product. A preliminary injunction being vacated means a court has lifted a prior restraining order that had restricted the company regarding this product. This development removes a previous legal hurdle around LEQSELVI. The company can now resume or continue with its plans for the product without the prior court-imposed restriction.
Positive for Sun Pharma shareholders — the lifting of the preliminary injunction removes a legal overhang on LEQSELVI, potentially allowing the company to commercialize or continue selling the product without court restrictions, which could support future revenue contribution.